Conclusion:
Although possibly rare, we propose that carbamazepine should be considered as a culprit for oropharyngeal dysphagia, especially in patients with underlying neurologic disease. Due to carbamazepine’s ability to inhibit neuronal depolarization, it is possible that these medications can lead to increased oropharyngeal dysfunction in certain patient populations. Clinicians should be aware of the existence of carbamazepine-induced-dysphagia, especially when treating patients with progressive neurologic disease and multiple comorbidities requiring polypharmacy.